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A B S T R A C T
BACKGROUND: A cardiac device (CD) infection is a very important challenge for 
cardiology and clinical microbiology specialists, because of the increasing use of im-
plantable CDs. Several host- and procedure-related factors increase the risk of CD 
infection. A CD infection commonly involves a permanent pacemaker (PPM) or an 
implantable cardioverter defibrillator (ICD) device, which like any other foreign body 
can become infected. Cardiac device infection may be a primary infection when the 
device and/or pocket itself is the source of infection, usually due to contamination 
at the time of implant or a secondary infection due to bacteremia from a different 
source contaminating the leads and/or the device and/or the pocket. Cardiac device 
infections are generally considered as pocket infections when the infection involves 
the subcutaneous pocket containing the device and the subcutaneous segment of 
the lead. The outcome is associated with the patient’s status, the echocardiographic 
findings and the type of the isolated microorganism. When microorganisms adhere 
to device’s surface form biofilms and serious complications ensue which are associ-
ated with significant morbidity and mortality. The purpose of this study was to assess 
recent data in a tertiary hospital for management of CD infection according to the 
proper antiobiotic therapy on the basis of the responsible microbiological factors and 
antibiotic susceptibility testing.
METHODS: Over the last one year clinical samples from patients with suspected 
CD infection were microbiologically examined with Gram and Ziehl - Neelsen stains, 
cultured in common and selective medium in aerobic, CO
2
 και anaerobic conditions 
as well as in automated BACTEC system. The identification of the isolated microor-
ganisms and the antibiotic susceptibility testing was performed with the automated 
system VITEK 2, API32Α, API 20A (BioMerieux), E test (AB Biodisk) and other 
complementary tests.
RESULTS: A total of 118 clinical samples with possible CD infection out of 552 
patients with implantable CDs (21.3%) were examined in our hospital. Sixty per cent 
were male. The median age of patients was 61.5 years. Clinical evidence of CD infection 
included several signs and symptoms such as local signs of inflammation, erythema, 
pain, swelling, warmth, wound dehiscence, erosion, tenderness or purulent drainage, 
skin ulceration, generator/lead erosion, intraoperative purulence at generator pocket 
or several laboratory test abnormalities such as leukocytosis or anemia. A total of 37 
patients with positive cultures out of 118 (31.3%) were included in the study, whereas 
5 patients had polymicrobial infection. Devices included 35 PPMs and 2 ICDs. A CD 
infection was microbiologically confirmed based on positive cultures from cardiac device 
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infection specimens as shown in Table 1 below.
Relapse was defined only in one patient, i.e. the recur-
rence of the device infection with the same organism based 
on similar antibiogram. A CD infection occurred after initial 
device implantation in 35 patients and after a revision (i.e., 
system upgrade, lead revision, or generator replacement) in 2 
patients. Sixty-three microorganisms were isolated as shown 
in Table 2 below.
CONCLUSIONS: In 37 out of 118 patients with suspected CD 
infection (31.4%) microbiological infection was confirmed. 
The predominant causative CD infection pathogens included 
common skin flora microorganisms, i.e. Gram positive cocci, 
such as coagulase negative staphylocci (CoNS), S. aureus, 
Aerococcus viridans, Streptococcus spp. and Peptococcus spp. 
The main etiological agents were Staphylococci followed by 
gram-negative bacilli including Klebsiella pneumoniae, Proteus 
mirabilis, Pseudomonas aeruginosa, Acinetobacter baumanii, 
Citrobacter koseri, Stenotrophomonas maltophilia and Bacte-
roides fragilis. CoNS (n=22) were the most common cause of 
CD infection with 50% methicillin-resistant strains. S. aureus 
infection is very important because of methicillin-resistant 
strains (MRSA 3 out of 5 strains S. aureus). No fungi or my-
cobacteria were detected as etiological agents. The majority 
(70%) of cases presented with a pus infection and a minor-
ity (29.7%) had PPM or ICD or electrode related infection. 
Polymicrobial infection was present in 3 (8.1%) patients. In 
81 out of 118 suspected CD infection patients (68.6%) with 
localized inflammatory signs at generator pocket or erosion of 
device/lead the cultures were negative. Because Staphylococci 
were the most common pathogens for CD infection cases, 
empiric antibiotics for suspected CD infection should include 
TABLE 1.
Cardiac device infection Specimen  n %
generator pocket  5 13.5
electrode leads  6 16.2
pus from the concerning area 26 70.3
Total 37
TABLE 2.
Gram positive cocci Gram negative bacilli
Aerobic microorganisms
Staphylococcus epidermidis 17 Klebsiella 
pneumoniae
7
Staphylococcus aureus 5 Proteus mirabilis 6
Staphylococcus hominis 3 Pseudomonas 
aeruginosa
4
Enterococcus faecalis 2 Acinetobacter 
baumanii
4
Staphylococcus 
haemolyticus
1 Citrobacter koseri 3
Staphylococcus capitis 1 Stenotrophomonas 
maltophilia
1
Aerococcus viridans 1
Streptococcus parasanguis 1
Streptococcus anginosus 1
Total 32 Total 26
Anaerobic microorganisms
Peptococcus spp. 1 Bacteroides fragilis 
group
1
Total 33 Total 27
coverage for staphylococci while awaiting microbiological 
results. These findings should assist clinicians in identifying 
CD infection patients who are at increased risk of infection, 
as well as in developing strategies to minimize the modifiable 
risks. All patients received antimicrobial treatment. Most 
patients (97%) received a combination of intravenous and 
oral antibiotics. Only 3% were treated with oral antibiotics 
alone. Patients with inescapable contamination of the site 
when part of the device or lead erodes through the overlying 
skin without proven evidence of infection must be treated as 
pocket infections. The very important point is that only in 37 
patients out of 552 implantable CDs (6.7%) we proved CD 
infection in our studied cohort.
